Drug record
What four public record sets show for lisdexamfetamine. Saved Nov 10, 2026.
| Shortage | On the FDA shortage list | Details |
|---|---|---|
| Pharmacy cost | $2.49 each for the lowest-cost generic | Details |
| Medicare Part D, 2024 | $133.3 million | Details |
| FDA recall records | 11 | Details |
Whether the FDA lists this drug as in short supply.
Reason given: Other
Reason given: Shortage of an active ingredient
Reason given: Shortage of an active ingredient
Reason given: Shortage of an active ingredient
Reason given: Shortage of an active ingredient
Reason given: Shortage of an active ingredient
Reason given: Shortage of an active ingredient
Reason given: Shortage of an active ingredient
Reason given: Shortage of an active ingredient
Showing 30 of at least 100. See all of them live.
The list changes daily, and it covers the national supply. A pharmacy near you can be out of a drug that is not listed, or have one that is. See today's status.
The national average price retail pharmacies pay to buy it (NADAC).
The lowest-cost generic on file is Lisdexamfetamine 20 Mg Capsule: pharmacies pay about $2.49 each, or $74.56 for 30.
| Product as surveyed | Type | Pharmacy pays | For 30 | Price since |
|---|---|---|---|---|
| LISDEXAMFETAMINE 10 MG CAPSULE | Generic | $2.54 per each | $76.26 | Oct 21, 2026 |
| LISDEXAMFETAMINE 10 MG TB CHEW | Generic | $3.79 per each | $113.71 | Oct 21, 2026 |
| LISDEXAMFETAMINE 20 MG CAPSULE | Generic | $2.49 per each | $74.56 | Oct 21, 2026 |
| LISDEXAMFETAMINE 20 MG TB CHEW | Generic | $4.32 per each | $129.67 | Oct 21, 2026 |
| LISDEXAMFETAMINE 30 MG CAPSULE | Generic | $2.88 per each | $86.54 | Oct 21, 2026 |
| LISDEXAMFETAMINE 30 MG TB CHEW | Generic | $3.87 per each | $116.00 | Oct 21, 2026 |
| LISDEXAMFETAMINE 40 MG CAPSULE | Generic | $2.66 per each | $79.77 | Oct 21, 2026 |
| LISDEXAMFETAMINE 40 MG TB CHEW | Generic | $4.17 per each | $125.21 | Oct 21, 2026 |
| LISDEXAMFETAMINE 50 MG CAPSULE | Generic | $2.73 per each | $81.84 | Oct 21, 2026 |
| LISDEXAMFETAMINE 50 MG TB CHEW | Generic | $3.68 per each | $110.41 | Oct 21, 2026 |
| LISDEXAMFETAMINE 60 MG CAPSULE | Generic | $2.61 per each | $78.15 | Oct 21, 2026 |
| LISDEXAMFETAMINE 60 MG TB CHEW | Generic | $3.58 per each | $107.29 | Oct 21, 2026 |
| LISDEXAMFETAMINE 70 MG CAPSULE | Generic | $2.61 per each | $78.15 | Oct 21, 2026 |
| VYVANSE 10 MG CAPSULE | Brand | $12.35 per each | $370.40 | Oct 21, 2026 |
| VYVANSE 10 MG CHEWABLE TABLET | Brand | $12.35 per each | $370.57 | Oct 21, 2026 |
| VYVANSE 20 MG CAPSULE | Brand | $12.35 per each | $370.36 | Oct 21, 2026 |
| VYVANSE 20 MG CHEWABLE TABLET | Brand | $12.34 per each | $370.32 | Oct 21, 2026 |
| VYVANSE 30 MG CAPSULE | Brand | $12.34 per each | $370.28 | Oct 21, 2026 |
| VYVANSE 30 MG CHEWABLE TABLET | Brand | $12.35 per each | $370.41 | Oct 21, 2026 |
| VYVANSE 40 MG CAPSULE | Brand | $12.35 per each | $370.39 | Oct 21, 2026 |
| VYVANSE 40 MG CHEWABLE TABLET | Brand | $12.35 per each | $370.62 | Oct 21, 2026 |
| VYVANSE 50 MG CAPSULE | Brand | $12.35 per each | $370.36 | Oct 21, 2026 |
| VYVANSE 50 MG CHEWABLE TABLET | Brand | $12.35 per each | $370.58 | Oct 21, 2026 |
| VYVANSE 60 MG CAPSULE | Brand | $12.35 per each | $370.64 | Oct 21, 2026 |
| VYVANSE 60 MG CHEWABLE TABLET | Brand | $12.36 per each | $370.75 | Oct 21, 2026 |
| VYVANSE 70 MG CAPSULE | Brand | $12.35 per each | $370.52 | Oct 21, 2026 |
This is not your price. NADAC is the national average that retail pharmacies pay to buy the drug, from the Medicaid survey for the week of Nov 11, 2026. What you pay adds the pharmacy's markup and dispensing fee and depends on your insurance or any discount card. "For 30" is shown only for products priced per tablet or capsule. Brand prices here are before any rebates.
Medicare Part D spending by product, from the latest annual file (2024).
In 2024, Medicare Part D plans and their members paid $133.3 million for the 2 products below. That is up 39% from $95.9 million in 2020.
| Product | 2024 spending | People | Per prescription | Per person, year | 2020 spending |
|---|---|---|---|---|---|
| Vyvanse Lisdexamfetamine Dimesylate | $88.8 million | 41,415 | $418.19 | $2,144.84 | $95.9 million |
| Lisdexamfetamine Dimesylate Lisdexamfetamine Dimesylate | $44.5 million | 46,077 | $225.27 | $965.76 | — |
Spending is the gross amount paid at the pharmacy by Part D plans and patients, before manufacturer rebates, which can be large for brand drugs. The same person can use more than one product, so people are not added up across rows. A dash means the file suppresses a small number or has no figure for that year.
Recalls reported to the FDA that name this drug.
The FDA has 11 recall records that name lisdexamfetamine in the product description (10 Class II · 1 Class III). 8 are still marked ongoing.
Lisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 57664-051-88.
Reason: Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.
Lisdexamfetamine Dimesylate Capsules, 50 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 57664-050-88.
Reason: Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.
Lisdexamfetamine Dimesylate Capsules, 70 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 57664-052-88.
Reason: Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.
Lisdexamfetamine Dimesylate Capsules, 20 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 57664-047-88.
Reason: Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.
Lisdexamfetamine Dimesylate Capsules, 10 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 57664-046-88.
Reason: Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.
Lisdexamfetamine Dimesylate Capsules, 40 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 57664-049-88.
Reason: Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.
Lisdexamfetamine Dimesylate Capsules, 30 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 57664-048-88.
Reason: Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.
Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC 0527-4664-37
Reason: Labeling: Label Mix-up. A bottle labeled as Lisdexamphetamine Dimesylate Capsules 40mg, contained Lisdexamphetamine Dimesylate Capsules 30mg.
Lisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottles, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceuticals, Inc., Cranbury, NJ 08512, NDC 57664-051-88
Reason: Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 9 month long term stability station (25¿C, 60%RH).
Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, Distributed by: Lannet Company, Philadelphia, PA 19136, NDC: 0527-4661-37
Reason: Failed Content Uniformity Specifications: Product failed to meet the action limits for stratified content uniformity.
Vyvanse (lisdexamfetamine dimesylate) Capsules 30 mg, 100 count bottle, Rx Only, Manufactured for: Shire US, Inc., Lexington, MA 02421, NDC 59417-103-10
Reason: Presence of Foreign Tablets/Capsules
A recall covers specific lots from one company, not every bottle of the drug. Records include combination products and compounded versions that name this ingredient. Class I is the most serious: use could cause serious harm. Class II may cause temporary or reversible harm. Class III is unlikely to cause harm. To check a bottle, match the lot number on the label. See the live list. Do not stop a medicine because of a recall without asking your pharmacist.
These are saved records as of Nov 10, 2026; the sources update daily to yearly. For current figures open the live report for lisdexamfetamine. This page is public-record information, not medical advice.